108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 72. 229960002117 Triamcinolone Acetonide Drugs 0.000 claims description 84. YNDXUCZADRHECN-JNQJZLCISA-N Triamcinolone acetonide Chemical compound YNDXUCZADRHECN-JNQJZLCISA-N 0.000 claims description 86. 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 92. 238000003780 insertion Methods 0.000 claims abstract description 62. 206010030032 Ocular disorder Diseases 0.000 claims abstract description 65. 229960005294 triamcinolone Drugs 0.000 claims abstract description 88. GFNANZIMVAIWHM-OBYCQNJPSA-N Triamcinolone Chemical compound GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 claims abstract description 95. 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 235. 239000003814 drug Substances 0.000 claims abstract description 333. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201261724144P external-priority Application filed by Clearside Biomedical Inc filed Critical Clearside Biomedical Inc Application granted granted Critical Publication of ES2813869T3 publication Critical patent/ES2813869T3/en Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links Original Assignee Clearside Biomedical Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Vladimir Zarnitsyn Samirkumar Patel Daniel White Glenn Noronha Brian Burke Current Assignee (The listed assignees may be inaccurate. 
Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number ES13853777T Other languages Spanish ( es)
#Clinica campo optimage pdf#
Methods for the treatment of eye disease in human subjectsĭownload PDF Info Publication number ES2813869T3 ES2813869T3 ES13853777T ES13853777T ES2813869T3 ES 2813869 T3 ES2813869 T3 ES 2813869T3 ES 13853777 T ES13853777 T ES 13853777T ES 13853777 T ES13853777 T ES 13853777T ES 2813869 T3 ES2813869 T3 ES 2813869T3 Authority ES Spain Prior art keywords drug pharmaceutical formulation microneedle eye scs Prior art date Legal status (The legal status is an assumption and is not a legal conclusion.
0 kommentar(er)
